Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries.
IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow.
In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians’ existing workflow.
Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL
ISI- bit.ly/2x9TiR4
IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow.
In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians’ existing workflow.
Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL
ISI- bit.ly/2x9TiR4
Location: United States, California, Santa Clara
Employees: 501-1000
Total raised: $132.5M
Founded date: 2009
Investors 3
Funding Rounds 4
| Date | Series | Amount | Investors |
| 10.10.2017 | - | $35M | - |
| 22.11.2016 | Series C | $45M | - |
| 19.05.2015 | - | $40M | - |
| 27.01.2014 | Series A | $12.5M | - |
Mentions in press and media 33
| Date | Title | Description |
| 31.03.2026 | Sonder Capital: Second Fund Futures II Closed To Advance AI-Enabled Medical Robotics And Minimally Invasive Therapies | Sonder Capital, a healthcare venture capital firm focused on transforming standards of care, announced the closing of its second fund, Futures II. The fund includes participation from major healthcare systems, including Mayo Clinic and Sutt... |
| 07.09.2025 | Galvanize Therapeutics Secures $100M: Revolutionizing Oncology and Chronic Lung Disease Treatment | Galvanize Therapeutics landed a significant $100 million Series C financing. This substantial capital propels its innovative pulsed electric field (PEF) therapies. The Redwood City firm targets critical unmet needs in oncology and chronic l... |
| 06.09.2025 | Galvanize Therapeutics: $100 Million Raised For Advancing Therapies For Cancer And Chronic Lung Disease | Galvanize Therapeutics, a commercial-stage medical technology company developing novel pulsed electric field therapies, has announced the successful close of a $100 million Series C financing round. The round was oversubscribed, reflecting ... |
| 03.09.2025 | Galvanize Therapeutics Raises $100M in Series C Financing | Galvanize Therapeutics, Redwood City, CA-based commercial-stage medical technology company advancing pulsed electric field (PEF) therapies for oncology and chronic lung disease, raised a $100m Series C financing. The round was led by Sofinn... |
| 29.10.2024 | Shockwave Medical completes enrollment in all-female IVL study | The Shockwave IVL. [Image from Shockwave Medical]Shockwave Medical, now part of Johnson & Johnson MedTech, has completed enrollment for its Empower CAD all-female study on percutaneous coronary intervention (PCI) in complex calcific cor... |
| 16.08.2024 | The Rise of Innovation: Neptune Medical and Findem Forge New Paths in Healthcare and Talent Acquisition | In the ever-evolving landscape of technology and healthcare, two companies are making waves. Neptune Medical and Findem are not just participants; they are leaders, carving out niches that promise to reshape their respective industries. Nep... |
| 15.08.2024 | Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular | BURLINGAME, Calif.–(BUSINESS WIRE)–August 15, 2024– Neptune Medical, a leader in medical device innovation, today announced the successful spinout of its subsidiary, Jupiter Endovascular, following the completion of a $97 million Series D f... |
| 25.07.2024 | Shockwave Medical Japan and Heart Organization begin collaboration on specialist technical support platform to raise awareness of treatment using intravascular lithotripsy for intravascular calcified ... | Shockwave Medical Japan and Heart Organization begin collaboration on specialist technical support platform to raise awareness of treatment using intravascular lithotripsy for calcified lesions in blood vessels *Heart Organization Co., Ltd.... |
| 25.07.2024 | Shockwave Medical Japan and Heart Organization begin collaboration on specialist technical support platform to raise awareness of treatment using intravascular lithotripsy for intravascular calcified ... | - |
| 17.07.2024 | Healthcare M&A Volume Drops in Q2:24, According to Acquisition Data from LevinPro HC | LevinPro HC Healthcare merger and acquisition activity slightly decreased in the second quarter of 2024, with 496 deals announced, according to new acquisition data from LevinPro HC. Activity in the Q2:24 was 2% lower than in the first quar... |
Show more